Bottom line
OUSM vs SBIO: the short answer
OUSM (ALPS | O'Shares U.S. Small-Cap Quality Dividend ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both etfs.
OUSM is cheaper at 0.48% vs 0.5% — a difference of $2.00 a year per $10,000 invested.
Over five years, OUSM returned +9.0% a year vs +0.7% for SBIO.
Updated Nov 19, 2026
OUSM vs SBIO side by side
| OUSM | SBIO | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Alps | Alps |
| Category | Dividend & Equity Income | Health Care Sector |
| Expense ratio | 0.48% | 0.5% |
| Annual cost per $10k | $48 | $50 |
| 10-yr cost on $10k (prospectus) | $603 | $628 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +2.2% | +54.2% |
| 5-yr return (annualized) | +9.0% | +0.7% |
| 10-yr return (annualized) | — | +5.7% |
| Best quarter | +19.3% | +33.9% |
| Worst quarter | −28.2% | −30.8% |
| Net assets (fund) | $876.9M | $161.8M |
| Number of holdings | 110 | 89 |
| Portfolio turnover | 39% | 58% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | OUSM | SBIO | Difference |
|---|---|---|---|
| 2025 | +2.2% | +54.2% | −52.1% |
| 2024 | +13.4% | +4.2% | +9.2% |
| 2023 | +18.8% | +8.2% | +10.6% |
| 2022 | −7.9% | −27.9% | +20.0% |
| 2021 | +21.6% | −17.5% | +39.1% |
| 2020 | +7.6% | +21.2% | −13.6% |
| 2019 | +27.6% | +49.9% | −22.2% |
| 2018 | −10.3% | −11.2% | +0.9% |
| 2017 | +10.7% | +44.9% | −34.2% |
Source: Fund prospectus bar charts
Holdings overlap
OUSM and SBIO share none of their top holdings.
OUSM top 10
- Td Synnex Corp — 3.46%
- Avnet Inc — 3.24%
- National Healthcare Corp — 3.23%
- Royalty Pharma Plc — 3.07%
- Texas Roadhouse Inc — 2.18%
- Littelfuse Inc — 2.16%
- Lincoln Electric Holdings Inc — 2.15%
- Skyworks Solutions Inc — 2.10%
- Donaldson Co Inc — 2.02%
- Sei Investments Co — 2.02%
SBIO top 10
- Alkermes Plc — 4.48%
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Xenon Pharmaceuticals Inc — 2.90%
- Travere Therapeutics Inc — 2.77%
- Dianthus Therapeutics Inc — 2.64%
FAQ
What is the difference between OUSM and SBIO?
OUSM (ALPS | O'Shares U.S. Small-Cap Quality Dividend ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both etfs. OUSM is cheaper at 0.48% vs 0.5% — a difference of $2.00 a year per $10,000 invested.
Which is cheaper, OUSM or SBIO?
OUSM has the lower expense ratio (0.48%).
Should I own both OUSM and SBIO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.